| Name | CBU_DIFF |
| Description | Differential CBU inventory message |
| Field description (WMDA dictionary field) | EMDIS field code | Required | Field Type |
|---|---|---|---|
| Sending EMDIS registry (REG_SND) | REG_SND | Optional | N4 |
| Receiving EMDIS registry (REG_RCV) | REG_RCV | Optional | N4 |
| The unit identification assigned by the hub. It may be the same as the local ID (CB_LOCAL_ID) (Cord Blood Unit Identification) | CB_ID | Required | A17 |
| Global registration identifier for donors (old format, deprecated).For information regarding GRID in the new format please see field D_GRID. (GRID) | GRID | Optional | A19 |
| Physical location of the donor (Donor location identifier) | DON_POOL | Required | N4 |
| Donor attribute (Donor Attribute) | DON_ATTR | Optional | A3 |
| The identification of the CBU locally at the cord blood bank (Local unit ID) | CB_LOCAL_ID | Optional | A17 |
| The identification as it appears on the bag. If more than one bag is available, do not fill in this field. (Unit Bag ID) | CB_BAG_ID | Optional | A17 |
| The ID of the bank that manufactured the unit (Cord Blood Bank Manufacturing ID) | CB_BANK_MANUF_ID | Optional | A10 |
| The ID of the bank distributing the unit. This may be different to the manufacturer (Cord Blood Bank) | CB_BANK_DISTRIB_ID | Optional | A10 |
| The identification of the maternal donor as assigned by the hub. It may be the same as the local ID (CB_BANK_MAT_ID) (Maternal ID) | CB_MAT_ID | Optional | A15 |
| The identification used to identify the maternal donor (Maternal ID) | CB_BANK_MAT_ID | Optional | A15 |
| Status (used to determine unit availability) (Search Status) | CB_STATUS | Required | A2 |
| Reason for status change (Search Status change) | CB_STAT_REASON | Optional | A2 |
| Status valid until specified date (e.g. assigned if the unit is temporarily unavailable) (Status end date) | CB_STAT_END_DATE | Optional | D8 |
| CBU Date of birth (date the infant was born) (Date of birth) | CB_BIRTH_DATE | Optional | D8 |
| CBU Collection date (Unit collection date) | CB_COLL_DATE | Optional | D8 |
| CBU sex (Sex) | CB_SEX | Optional | A1 |
| CBU blood group (Blood Group (ABO)) | CB_ABO | Optional | A3 |
| CBU ethnic group (Ethnicity) | CB_ETHN | Optional | A4 |
| CBU CCR5 status (CCR5) | CB_CCR5 | Optional | A2 |
| CBU Processing start date (Unit processing Date) | CB_PROC_DATE | Optional | D8 |
| Processing methods (Unit processing system) | CB_PROC_METH | Optional | A3 |
| Processing method type (Unit processing method) | CB_PROC_METH_TYPE | Optional | A3 |
| CBU freezing date (Unit cryopreservation date) | CB_FREEZE_DATE | Optional | D8 |
| CBU freezing method (Unit cryopreservation method) | CB_FREEZE_METH | Optional | A1 |
| Product modifications (Unit product modification) | CB_PROD_MOD | Optional | A3 |
| Type of bag used (CBU bag fractions / split unit) (Unit Bag Type) | CB_TYP_BAG | Optional | A5 |
| Number of bags for the cord blood sub units (Number of Unit bags) | CB_BAGS | Optional | N2 |
| Bacterial culture (Microbial Screen(bacteria)) | CB_BACT_CULT | Optional | A1 |
| Fungal culture (Unit microbial screen (fungal)) | CB_FUNG_CULT | Optional | A1 |
| Hemoglobinopathy screening status (Hemoglobinopathy screen) | CB_HEMO_STATUS | Optional | A2 |
| CBU collected volume before processing (without additives) (Unit volume at collection) | CB_VOL | Optional | R5 |
| Total CBU volume frozen (post processing and pre-cryopreservation) (Unit volume at cryopreservation) | CB_VOL_FRZN | Optional | R5 |
| Processed total number of nucleated cells (post processing and pre-cryopreservation) (Total nucleated Cells (TNC) in CBU) | CB_TNC_FRZN | Optional | F7 |
| Total nucleated red blood cell count (post processing and pre-cryopreservation) reflecting the content of the final product that is frozen (Total Nucleated Red Blood cells) | CB_RED_BC_FRZN | Optional | F7 |
| Collected total number of mononucleated cells (post processing and pre-cryopreservation)) (Collected number of unit mononuclear cells) | CB_MNC_FRZN | Optional | F7 |
| Processed total number of CD34+ cells. Post processing and pre-cryopreservation. (Processed CD34+) | CB_CD34PC_FRZN | Optional | F7 |
| Total CFU post processing count (post processing and pre-cryopreservation). GM method (Total colony forming units (CFU)) | CB_CFU_FRZN | Optional | F7 |
| Viability for collected total nucleated cells count Viability of CB_VIABILITY_CELLS (Unit viability) | CB_VIABILITY | Optional | N3 |
| Type of cells tested for viability (Unit viability type) | CB_VIABILITY_CELLS | Optional | A4 |
| Method used to calculate the viability (Viability Method) | CB_VIABILITY_METHOD | Optional | A2 |
| Date viability was tested (Viability Date) | CB_VIABILITY_DATE | Optional | D8 |
| Number of attached segments available (Contigous/attached segments) | CB_ATT_SEG | Optional | N2 |
| Other type samples available (other than DNA) (Other viable cell aliquots) | CB_OTH_SMPL | Optional | A1 |
| CBU DNA samples available (Unit DNA sample availability) | CB_DNA_SMPL | Optional | A1 |
| Verification typing (CT) date of the cord blood unit. Definition: CT (Confirmatory Typing) is repeat DNA typing after registration. For the CT to be completed, loci A, B, and DRB1 must all be retested and confirmed consistent with registration typing. The CT completion date is the latest date when A, B, and DRB1 are all complete. If the loci are not all tested at the same time, this date will be the date the last locus was tested. (Unit verification typing date) | CB_CT_COMPLETE_DATE | Optional | D8 |
| CT Sample type (Unit confirmatory typing sample type) | CB_CT_SMPL_TYPE | Optional | A2 |
| CBU HLA-A, 1st antigen (HLA-A (serological)) | CB_A1 | Optional | A5 |
| CBU HLA-A, 2nd antigen (HLA-A (serological)) | CB_A2 | Optional | A5 |
| CBU HLA-B, 1st antigen (HLA-B (serological)) | CB_B1 | Optional | A5 |
| CBU HLA-B, 2nd antigen (HLA-B (serological)) | CB_B2 | Optional | A5 |
| CBU HLA-C, 1st antigen (HLA-C (serological)) | CB_C1 | Optional | A5 |
| CBU HLA-C, 2nd antigen (HLA-C (serological)) | CB_C2 | Optional | A5 |
| CBU HLA-DR, 1st antigen (HLA-DRB1 (serological)) | CB_DR1 | Optional | A5 |
| CBU HLA-DR, 2nd antigen (HLA-DRB1 (serological)) | CB_DR2 | Optional | A5 |
| CBU HLA-DQ, 1st antigen (HLA-DQB1 (serological)) | CB_DQ1 | Optional | A5 |
| CBU HLA-DQ, 2nd antigen (HLA-DQB1 (serological)) | CB_DQ2 | Optional | A5 |
| CBU DNA-A, 1st allele (HLA-A (molecular)) | CB_DNA_A1 | Optional | A20 |
| CBU DNA-A, 2nd allele (HLA-A (molecular)) | CB_DNA_A2 | Optional | A20 |
| CBU DNA-B, 1st allele (HLA-B (molecular)) | CB_DNA_B1 | Optional | A20 |
| CBU DNA-B, 2nd allele (HLA-B (molecular)) | CB_DNA_B2 | Optional | A20 |
| CBU DNA-C, 1st allele (HLA-C (molecular)) | CB_DNA_C1 | Optional | A20 |
| CBU DNA-C, 2nd allele (HLA-C (molecular)) | CB_DNA_C2 | Optional | A20 |
| CBU DNA-DRB1, 1st allele (HLA-DRB1 (molecular)) | CB_DRB11 | Optional | A20 |
| CBU DNA-DRB1, 2nd allele (HLA-DRB1 (molecular)) | CB_DRB12 | Optional | A20 |
| CBU DNA-DRB3, 1st allele (HLA-DRB3 (molecular)) | CB_DRB31 | Optional | A20 |
| CBU DNA-DRB3, 2nd allele (HLA-DRB3 (molecular)) | CB_DRB32 | Optional | A20 |
| CBU DNA-DRB4, 1st allele (HLA-DRB4 (molecular)) | CB_DRB41 | Optional | A20 |
| CBU DNA-DRB4, 2nd allele (HLA-DRB4 (molecular)) | CB_DRB42 | Optional | A20 |
| CBU DNA-DRB5, 1st allele (HLA-DRB5 (molecular)) | CB_DRB51 | Optional | A20 |
| CBU DNA-DRB5, 2nd allele (HLA-DRB5 (molecular)) | CB_DRB52 | Optional | A20 |
| CBU DNA-DQA1, 1st allele (HLA-DQA1 (molecular)) | CB_DQA11 | Optional | A20 |
| CBU DNA-DQA1, 2nd allele (HLA-DQA1 (molecular)) | CB_DQA12 | Optional | A20 |
| CBU DNA-DQB1, 1st allele (HLA-DQB1 (molecular)) | CB_DQB11 | Optional | A20 |
| CBU DNA-DQB1, 2nd allele (HLA-DQB1 (molecular)) | CB_DQB12 | Optional | A20 |
| CBU DNA-DPA1, 1st allele (HLA-DPA1 (molecular)) | CB_DPA11 | Optional | A20 |
| CBU DNA-DPA1, 2nd allele (HLA-DPA1 (molecular)) | CB_DPA12 | Optional | A20 |
| CBU DNA-DPB1, 1st allele (HLA-DPB1 (molecular)) | CB_DPB11 | Optional | A20 |
| CBU DNA-DPB1, 2nd allele (HLA-DPB1 (molecular)) | CB_DPB12 | Optional | A20 |
| CBU KIR gene 2DL1 (KIR gene 2DL1) | CB_KIR2DL1 | Optional | A255 |
| CBU KIR gene 2DL2 (KIR gene 2DL2) | CB_KIR2DL2 | Optional | A255 |
| CBU KIR gene 2DL3 (KIR gene 2DL3) | CB_KIR2DL3 | Optional | A255 |
| CBU KIR gene 2DL4 (KIR gene 2DL4) | CB_KIR2DL4 | Optional | A255 |
| CBU KIR gene 2DL5A (KIR gene 2DL5A) | CB_KIR2DL5A | Optional | A255 |
| CBU KIR gene 2DL5B (KIR gene 2DL5B) | CB_KIR2DL5B | Optional | A255 |
| CBU KIR gene 2DS1 (KIR gene 2DS1) | CB_KIR2DS1 | Optional | A255 |
| CBU KIR gene 2DS2 (KIR gene 2DS2) | CB_KIR2DS2 | Optional | A255 |
| CBU KIR gene 2DS3 (KIR gene 2DS3) | CB_KIR2DS3 | Optional | A255 |
| CBU KIR gene 2DS4 (KIR gene 2DS4) | CB_KIR2DS4 | Optional | A255 |
| CBU KIR gene 2DS5 (KIR gene 2DS5) | CB_KIR2DS5 | Optional | A255 |
| CBU KIR gene 2DP1 (KIR gene 2DP1) | CB_KIR2DP1 | Optional | A255 |
| CBU KIR gene 3DL1 (KIR gene 3DL1) | CB_KIR3DL1 | Optional | A255 |
| CBU KIR gene 3DL2 (KIR gene 3DL2) | CB_KIR3DL2 | Optional | A255 |
| CBU KIR gene 3DL3 (KIR gene 3DL3) | CB_KIR3DL3 | Optional | A255 |
| CBU KIR gene 3DS1 (KIR gene 3DS1) | CB_KIR3DS1 | Optional | A255 |
| CBU KIR gene 3DP1 (KIR gene 3DP1) | CB_KIR3DP1 | Optional | A255 |
| URI to a GL-String or GL-string for absence/presence for KIR typing results. (Killer immunoglobulin-like receptor (KIR) GL string) | CB_KIR_GL | Optional | A255 |
| CBU CMV status (CMV antibodies test result) | CB_ANTI_CMV | Optional | A1 |
| CBU Hepatitis B status (hepatitis B surface antigen) (Hepatitis B surface antigen test result) | CB_HBS_AG | Optional | A1 |
| CBU Hepatitis B status (antibody to hepatitis B core antigen) (Hepatitis B core antibody test result) | CB_ANTI_HBC | Optional | A1 |
| CBU Hepatitis C status (antibody to hepatitis C virus) (Hepatitis C virus (HCV) antibodies test result) | CB_ANTI_HCV | Optional | A1 |
| CBU Anti-HIV 1/2 status (HIV-1 and HIV-2 antibodies test result) | CB_ANTI_HIV_12 | Optional | A1 |
| CBU HIV-1 NAT status (HIV-1 NAT result) | CB_HIV_1_NAT | Optional | A1 |
| CBU HIV p24 status (HIV p24 antigen test result) | CB_HIV_P24 | Optional | A1 |
| CBU HCV NAT status (Hepatitis C virus (HCV) NAT result) | CB_HCV_NAT | Optional | A1 |
| CBU HTLV status (Human T-Lymphotropic Virus (HTLV) type 1/2 antibodies test result) | CB_ANTI_HTLV | Optional | A1 |
| CBU Syphilis status (Syphilis serological test result) | CB_SYPHILIS | Optional | A1 |
| CBU West Nile Virus (WNV) status (West Nile Virus (WNV) NAT result) | CB_WNV | Optional | A1 |
| CBU Chagas status (Chagas NAT result) | CB_CHAGAS | Optional | A1 |
| CBU EBV status (Epstein Barr Virus (EBV) antibodies test result) | CB_EBV | Optional | A1 |
| CBU Toxoplasmosis status (Toxoplasmosis antibodies test result) | CB_TOXO | Optional | A1 |
| CBU HBV NAT status (Hepatitis B virus (HBV) NAT result) | CB_HBV_NAT | Optional | A1 |
| CBU CMV NAT status (CMV NAT result) | CB_CMV_NAT | Optional | A1 |
| CBU ParvoB19 NAT status (Parvo-B19 PCR) | CB_PB19_NAT | Optional | A1 |
| The total number of CBU red cell fraction aliquots available for testing. These samples may be used for infectious disease testing (Unit red cell aliquots) | CB_AL_RED_BC | Optional | N2 |
| Number of CBU serum aliquots available (Unit serum aliquots) | CB_AL_SER | Optional | N2 |
| Total volume of CBU serum available (Unit serum available) | CB_SER_QUANT | Optional | R4 |
| The total number of CBU plasma aliquots available for testing. These samples may be used for infectious disease testing (Unit plasma aliquots) | CB_AL_PLA | Optional | N2 |
| Total quantity of CBU plasma available (Unit Plasma Available) | CB_PLA_QUANT | Optional | R4 |
| Maternal HLA-A, 1st antigen (HLA-A (serological)) | CB_MAT_A1 | Optional | A5 |
| Maternal HLA-A, 2nd antigen (HLA-A (serological)) | CB_MAT_A2 | Optional | A5 |
| Maternal HLA-B, 1st antigen (HLA-B (serological)) | CB_MAT_B1 | Optional | A5 |
| Maternal HLA-B, 2nd antigen (HLA-B (serological)) | CB_MAT_B2 | Optional | A5 |
| Maternal HLA-C, 1st antigen (HLA-C (serological)) | CB_MAT_C1 | Optional | A5 |
| Maternal HLA-C, 2nd antigen (HLA-C (serological)) | CB_MAT_C2 | Optional | A5 |
| Maternal HLA-DR, 1st antigen (HLA-DRB1 (serological)) | CB_MAT_DR1 | Optional | A5 |
| Maternal HLA-DR, 2nd antigen (HLA-DRB1 (serological)) | CB_MAT_DR2 | Optional | A5 |
| Maternal HLA-DQ, 1st antigen (HLA-DQB1 (serological)) | CB_MAT_DQ1 | Optional | A5 |
| Maternal HLA-DQ, 2nd antigen (HLA-DQB1 (serological)) | CB_MAT_DQ2 | Optional | A5 |
| Maternal DNA-A, 1st allele (HLA-A (molecular)) | CB_MAT_DNA_A1 | Optional | A20 |
| Maternal DNA-A, 2nd allele (HLA-A (molecular)) | CB_MAT_DNA_A2 | Optional | A20 |
| Maternal DNA-B, 1st allele (HLA-B (molecular)) | CB_MAT_DNA_B1 | Optional | A20 |
| Maternal DNA-B, 2nd allele (HLA-B (molecular)) | CB_MAT_DNA_B2 | Optional | A20 |
| Maternal DNA-C, 1st allele (HLA-C (molecular)) | CB_MAT_DNA_C1 | Optional | A20 |
| Maternal DNA-C, 2nd allele (HLA-C (molecular)) | CB_MAT_DNA_C2 | Optional | A20 |
| Maternal DNA-DRB1, 1st allele (HLA-DRB1 (molecular)) | CB_MAT_DRB11 | Optional | A20 |
| Maternal DNA-DRB1, 2nd allele (HLA-DRB1 (molecular)) | CB_MAT_DRB12 | Optional | A20 |
| Maternal DNA-DRB3, 1st allele (HLA-DRB3 (molecular)) | CB_MAT_DRB31 | Optional | A20 |
| Maternal DNA-DRB3, 2st allele (HLA-DRB3 (molecular)) | CB_MAT_DRB32 | Optional | A20 |
| Maternal DNA-DRB4, 1st allele (HLA-DRB4 (molecular)) | CB_MAT_DRB41 | Optional | A20 |
| Maternal DNA-DRB4, 2nd allele (HLA-DRB4 (molecular)) | CB_MAT_DRB42 | Optional | A20 |
| Maternal DNA-DRB5, 1st allele (HLA-DRB5 (molecular)) | CB_MAT_DRB51 | Optional | A20 |
| Maternal DNA-DRB5, 2nd allele (HLA-DRB5 (molecular)) | CB_MAT_DRB52 | Optional | A20 |
| Maternal DNA-DQA1, 1st allele (HLA-DQA1 (molecular)) | CB_MAT_DQA11 | Optional | A20 |
| Maternal DNA-DQA1, 2nd allele (HLA-DQA1 (molecular)) | CB_MAT_DQA12 | Optional | A20 |
| Maternal DNA-DQB1, 1st allele (HLA-DQB1 (molecular)) | CB_MAT_DQB11 | Optional | A20 |
| Maternal DNA-DQB1, 2nd allele (HLA-DQB1 (molecular)) | CB_MAT_DQB12 | Optional | A20 |
| Maternal DNA-DPA1, 1st allele (HLA-DPA1 (molecular)) | CB_MAT_DPA11 | Optional | A20 |
| Maternal DNA-DPA1, 2nd allele (HLA-DPA1 (molecular)) | CB_MAT_DPA12 | Optional | A20 |
| Maternal DNA-DRB1, 1st allele (HLA-DPB1 (molecular)) | CB_MAT_DPB11 | Optional | A20 |
| Maternal DNA-DRB1, 2nd allele (HLA-DPB1 (molecular)) | CB_MAT_DPB12 | Optional | A20 |
| Maternal CMV status (CMV antibodies test result) | CB_MAT_ANTI_CMV | Optional | A1 |
| Maternal Hepatitis B status (hepatitis B surface antigen) (Hepatitis B surface antigen test result) | CB_MAT_HBS_AG | Optional | A1 |
| Maternal Hepatitis B status (antibody to hepatitis B core antigen) (Hepatitis B core antibody test result) | CB_MAT_ANTI_HBC | Optional | A1 |
| Maternal Hepatitis B status (maternal Anti HBs) (Hepatitis B surface antibody test result) | CB_MAT_ANTI_HBS | Optional | A1 |
| Maternal Hepatitis C status (antibody to hepatitis C virus) (Hepatitis C virus (HCV) antibodies test result) | CB_MAT_ANTI_HCV | Optional | A1 |
| Maternal Anti-HIV 1/2 status (HIV-1 and HIV-2 antibodies test result) | CB_MAT_ANTI_HIV_12 | Optional | A1 |
| Maternal HIV-1 NAT status (HIV-1 NAT result) | CB_MAT_HIV_1_NAT | Optional | A1 |
| Maternal HIV p24 status (HIV p24 antigen test result) | CB_MAT_HIV_P24 | Optional | A1 |
| Maternal HCV NAT status (Hepatitis C virus (HCV) NAT result) | CB_MAT_HCV_NAT | Optional | A1 |
| Maternal HTLV status (Human T-Lymphotropic Virus (HTLV) type 1/2 antibodies test result) | CB_MAT_ANTI_HTLV | Optional | A1 |
| Maternal Syphilis status (Syphilis serological test result) | CB_MAT_SYPHILIS | Optional | A1 |
| Maternal West Nile Virus (WNV) status (West Nile Virus (WNV) NAT result) | CB_MAT_WNV | Optional | A1 |
| Maternal Chagas status (Chagas NAT result) | CB_MAT_CHAGAS | Optional | A1 |
| Maternal EBV status (Epstein Barr Virus (EBV) antibodies test result) | CB_MAT_EBV | Optional | A1 |
| Maternal Toxoplasmosis status (Toxoplasmosis antibodies test result) | CB_MAT_TOXO | Optional | A1 |
| Maternal HBV NAT status (Hepatitis B virus (HBV) NAT result) | CB_MAT_HBV_NAT | Optional | A1 |
| Maternal CMV NAT status (CMV NAT result) | CB_MAT_CMV_NAT | Optional | A1 |
| Maternal ParvoB19 NAT status (Parvo-B19 PCR) | CB_MAT_PB19_NAT | Optional | A1 |
| Number of serum maternal aliquots (Maternal serum aliquots) | CB_MAT_AL_SER | Optional | N2 |
| Total quantity of maternal serum available (Quantity of maternal serum) | CB_MAT_SER_QUANT | Optional | R4 |
| Number of plasma maternal aliquots (Maternal plasma aliquots) | CB_MAT_AL_PLA | Optional | N2 |
| Total quantity of maternal plasma available (Maternal plasma available) | CB_MAT_PLA_QUANT | Optional | R4 |
| Major version of the HLA Nomenclature in use[1] (HLA Nomenclature Version) | HLA_NOM_VER | Required | A7 |
The ID for Either
|